Rhode Island HB 7245: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE DRUG COST TRANSPARENCY ACT (Allows drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers for analysis to the director of the department of business regulation regarding prescription drugs.)

Status: 03/03/2022 Committee recommended measure be held for further study (as of 2022-03-03)

State: Rhode Island · Session: 2022 · Bill: HB 7245

Sponsors: Ackerman, Bennett, Cassar, Filippi, Kazarian, Kennedy, McGaw, McNamara

View Rhode Island HB 7245 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.